CN Stock MarketDetailed Quotes
600211 Tibet Rhodiola Pharmaceutical Holding
- 34.96
- -0.47-1.33%
Market Closed Jan 10 15:00 CST
11.27BMarket Cap15.28P/E (TTM)
35.62High34.92Low17.52KlotVolume35.26Open35.43Pre Close61.78MTurnover0.54%Turnover Ratio14.07P/E (Static)322.32MShares45.1252wk High3.10P/B11.27BFloat Cap25.4252wk Low38.97Limit Up322.32MShs Float136.37Historical High31.89Limit Down1.98%Amplitude-3.47Historical Low1.53Dividend TTM35.27Avg Price10.49KlotAsk4.39%Div YieldTTM100Lot Size6.38KlotBid
Tibet Rhodiola Pharmaceutical Holding Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -8.13%2.18B | -11.29%1.61B | -22.35%704.22M | 22.69%3.13B | 20.93%2.37B | 35.52%1.82B | 38.22%906.94M | 19.45%2.55B | 25.37%1.96B | 29.41%1.34B |
| Operating revenue | -8.13%2.18B | -11.29%1.61B | -22.35%704.22M | 22.69%3.13B | 20.93%2.37B | 35.52%1.82B | 38.22%906.94M | 19.45%2.55B | 25.37%1.96B | 29.41%1.34B |
| Other operating revenue | ---- | 34.59%3.66M | ---- | -35.64%6.24M | ---- | -19.98%2.72M | ---- | -19.61%9.69M | ---- | 62.94%3.4M |
| Total operating cost | -8.96%1.41B | -11.90%1.03B | -23.42%444.14M | 13.52%2.06B | 11.52%1.55B | 20.04%1.17B | 30.10%579.96M | 15.38%1.81B | 27.57%1.39B | 37.63%972.66M |
| Operating cost | -0.07%110.34M | -9.12%69.5M | -9.61%36.39M | 5.72%155.08M | 3.00%110.42M | 5.95%76.48M | 11.34%40.26M | -34.28%146.69M | -33.89%107.2M | -29.90%72.19M |
| Operating tax surcharges | 7.78%30.44M | 11.63%23.88M | -37.90%6.91M | 17.29%38.17M | 16.94%28.24M | 20.84%21.39M | 30.27%11.13M | 24.22%32.54M | 32.00%24.15M | 42.88%17.7M |
| Operating expense | -8.81%1.21B | -11.15%907.31M | -22.01%395.24M | 24.73%1.76B | 23.80%1.33B | 38.03%1.02B | 40.77%506.81M | 22.00%1.41B | 29.55%1.07B | 33.90%739.76M |
| Administration expense | -8.76%79.71M | -0.82%53.53M | 2.52%26.21M | -6.39%124M | -4.07%87.36M | -7.41%53.97M | -8.32%25.56M | 33.19%132.47M | 61.76%91.07M | 77.10%58.3M |
| Financial expense | -143.91%-41.83M | -173.25%-36.07M | -184.15%-23.53M | -885.60%-33.71M | -261.39%-17.15M | -274.42%-13.2M | -353.65%-8.28M | -36.43%4.29M | 348.12%10.63M | 920.67%7.57M |
| -Interest expense (Financial expense) | 2.25%9.22M | 8.01%5.26M | -25.68%2.41M | -19.25%11.59M | -19.89%9.01M | -38.65%4.87M | -8.67%3.25M | 231.71%14.36M | 82.44%11.25M | 144.45%7.93M |
| -Interest Income (Financial expense) | -82.80%-50.65M | -127.88%-43M | -137.29%-27.35M | -219.60%-45.78M | -330.39%-27.71M | -711.16%-18.87M | -886.44%-11.53M | -436.87%-14.32M | 10.74%-6.44M | 53.12%-2.33M |
| Research and development | 104.65%17.03M | 34.45%10.52M | -34.72%2.92M | -80.31%17.35M | -89.59%8.32M | -89.85%7.83M | -54.94%4.47M | 44.81%88.13M | 318.18%79.91M | 1,384.53%77.14M |
| Credit Impairment Loss | -380.75%-362.34K | -119.50%-362.22K | ---- | -127.64%-150.23K | 69.05%-75.37K | 31.52%-165.02K | --643.39 | -59.94%543.49K | -157.70%-243.53K | -157.09%-240.96K |
| Asset Impairment Loss | 98.46%-47.99K | 98.46%-48.05K | ---- | 29.89%-193.97M | 92.98%-3.12M | 92.98%-3.12M | ---- | 39.94%-276.66M | -3,086.71%-44.49M | -6,027.16%-44.49M |
| Other net revenue | -12.24%117.2M | 841.12%111.32M | 787.18%87.18M | 36.09%-176.94M | 332.97%133.53M | 119.89%11.83M | 179.10%9.83M | 10.80%-276.86M | -1,820.95%-57.32M | -2,491.97%-59.47M |
| Fair value change income | -50.68%-4.03M | -78.75%-4.37M | -3.06%-2.13M | -1,386.12%-210.53M | 83.80%-2.68M | 83.48%-2.44M | 81.89%-2.06M | -109.24%-14.17M | -676.15%-16.53M | -416.86%-14.8M |
| Invest income | -43.08%12.57M | -54.94%7.69M | -79.18%2.46M | 475.81%40.44M | 537.75%22.08M | 4,868.63%17.06M | 809.69%11.82M | 203.58%7.02M | 167.71%3.46M | 82.77%-357.7K |
| -Including: Investment income associates | -2.31%-2.28M | -71.08%-1.57M | -25.07%-754.12K | -92.13%-4.27M | 27.37%-2.23M | 68.94%-919.19K | 70.60%-602.97K | 77.05%-2.22M | 0.98%-3.07M | 10.64%-2.96M |
| Asset deal income | 1,895.41%2.08M | 1,944.76%2.08M | --168.34K | 6,867.21%533.93K | ---115.99K | ---112.56K | ---- | 121.42%7.66K | ---- | ---- |
| Other revenue | -8.90%106.99M | 17,186.97%106.34M | 123,872.13%86.68M | 2,821.15%186.74M | 24,279.71%117.44M | 48.00%615.13K | 4.96%69.92K | 160.28%6.39M | 104.14%481.71K | 111.56%415.62K |
| Operating profit | -7.36%884.45M | 4.95%697.33M | 3.11%347.27M | 93.50%899.09M | 85.81%954.75M | 113.61%664.46M | 70.17%336.81M | 80.94%464.65M | 8.94%513.83M | -6.79%311.06M |
| Add:Non operating Income | 8.58%789.52K | 764.43%649.69K | -51.86%209.47K | 684.26%2.61M | 277.15%727.13K | 32.58%75.16K | 2,095.82%435.1K | -91.97%332.45K | -96.33%192.79K | -92.79%56.69K |
| Less:Non operating expense | 198.73%2.42M | 602.06%2.11M | -75.71%35.93K | 120.00%3.51M | -41.81%808.76K | -62.19%300.25K | -53.01%147.95K | -73.83%1.59M | -76.25%1.39M | 96.73%794.12K |
| Total profit | -7.53%882.83M | 4.76%695.87M | 3.07%347.44M | 93.83%898.19M | 86.23%954.67M | 114.05%664.24M | 70.57%337.1M | 81.83%463.39M | 8.82%512.64M | -7.12%310.32M |
| Less:Income tax cost | -3.81%87.68M | 8.37%69.79M | 1.96%32.2M | -0.15%87.95M | 38.81%91.15M | 42.71%64.4M | 47.74%31.58M | 110.60%88.08M | 32.81%65.67M | 33.91%45.13M |
| Net profit | -7.92%795.15M | 4.38%626.08M | 3.18%315.24M | 115.89%810.24M | 93.19%863.52M | 126.19%599.83M | 73.34%305.52M | 76.18%375.31M | 6.01%446.97M | -11.72%265.19M |
| Net profit from continuing operation | -7.92%795.15M | 4.38%626.08M | 3.18%315.24M | 115.89%810.24M | 93.19%863.52M | 126.19%599.83M | 73.34%305.52M | 76.18%375.31M | 6.01%446.97M | -11.72%265.19M |
| Less:Minority Profit | -59.90%3.28M | -25.01%2.95M | 0.28%2.32M | 70.60%9.33M | 95.53%8.18M | 33.56%3.93M | 46.39%2.32M | 33.76%5.47M | 32.46%4.18M | 36.01%2.94M |
| Net profit of parent company owners | -7.42%791.87M | 4.57%623.14M | 3.21%312.92M | 116.56%800.91M | 93.17%855.34M | 127.23%595.9M | 73.59%303.2M | 77.01%369.84M | 5.81%442.79M | -12.07%262.25M |
| Earning per share | ||||||||||
| Basic earning per share | -7.17%2.46 | 4.32%1.93 | 3.28%1.26 | 116.78%3.23 | 48.04%2.65 | 74.53%1.85 | 74.29%1.22 | 77.38%1.49 | 5.92%1.79 | -11.67%1.06 |
| Diluted earning per share | -7.17%2.46 | 4.32%1.93 | 3.28%1.26 | 116.78%3.23 | 48.04%2.65 | 74.53%1.85 | 74.29%1.22 | 77.38%1.49 | 5.92%1.79 | -11.67%1.06 |
| Other composite income | -134.59%-12.08M | -83.86%6.72M | -93.67%1.82M | -80.68%18.24M | -70.10%34.92M | -24.93%41.66M | 733.53%28.67M | 425.38%94.4M | 1,736.85%116.79M | 549.07%55.5M |
| Other composite income of parent company owners | -134.59%-12.08M | -83.86%6.72M | -93.67%1.82M | -80.68%18.24M | -70.10%34.92M | -24.93%41.66M | 733.53%28.67M | 425.38%94.4M | 1,736.85%116.79M | 549.07%55.5M |
| Add:Adjusted items effecting composite income | --6.51K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total composite income | -12.84%783.07M | -1.35%632.81M | -5.13%317.06M | 76.38%828.48M | 59.37%898.44M | 100.04%641.5M | 94.61%334.19M | 155.25%469.71M | 36.01%563.75M | 11.33%320.69M |
| Total composite income of parent company owners | -12.41%779.79M | -1.21%629.86M | -5.16%314.73M | 76.45%819.15M | 59.10%890.26M | 100.65%637.57M | 95.05%331.87M | 158.02%464.24M | 36.03%559.57M | 11.15%317.75M |
| Total composite income of minority owners | -59.82%3.29M | -25.01%2.95M | 0.28%2.32M | 70.60%9.33M | 95.53%8.18M | 33.56%3.93M | 46.39%2.32M | 33.76%5.47M | 32.46%4.18M | 36.01%2.94M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Sichuan Huaxin (Group) Accounting Firm (Special General Partnership) | -- | -- | -- | Sichuan Huaxin (Group) Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
